{
 "drug": "Glycopyrrolate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/30/2026",
 "dayN": 26,
 "cat": "Anesthesia",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/30/2026",
   "update_type": "New",
   "initial_posting_date": "07/30/2026",
   "package_ndc": "63323-578-05",
   "generic_name": "Glycopyrrolate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA209328"
    ],
    "brand_name": [
     "GLYCOPYRROLATE"
    ],
    "generic_name": [
     "GLYCOPYRROLATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-578"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GLYCOPYRROLATE"
    ],
    "rxcui": [
     "238212",
     "1731582",
     "1731590"
    ],
    "spl_id": [
     "779dc924-ecc3-41cc-8cf9-a7354db4f763",
     "d528572e-598b-4c0e-b280-b083c73c017f"
    ],
    "spl_set_id": [
     "54458620-d888-4df6-ae4b-78c3dfed3423",
     "ccafb5c2-86dd-4bb2-883a-c13e3171227c"
    ],
    "package_ndc": [
     "63323-578-03",
     "63323-578-01",
     "63323-578-04",
     "63323-578-02",
     "63323-578-07",
     "63323-578-05",
     "63323-578-18",
     "63323-578-20",
     "63323-578-41",
     "63323-578-11",
     "63323-578-42",
     "63323-578-12"
    ],
    "unii": [
     "V92SO9WP2I"
    ]
   },
   "update_date": "07/30/2026",
   "therapeutic_category": [
    "Anesthesia"
   ],
   "dosage_form": "Injection",
   "presentation": "Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/30/2026",
   "update_type": "New",
   "initial_posting_date": "07/30/2026",
   "package_ndc": "63323-578-01",
   "generic_name": "Glycopyrrolate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA209328"
    ],
    "brand_name": [
     "GLYCOPYRROLATE"
    ],
    "generic_name": [
     "GLYCOPYRROLATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-578"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GLYCOPYRROLATE"
    ],
    "rxcui": [
     "238212",
     "1731582",
     "1731590"
    ],
    "spl_id": [
     "779dc924-ecc3-41cc-8cf9-a7354db4f763",
     "d528572e-598b-4c0e-b280-b083c73c017f"
    ],
    "spl_set_id": [
     "54458620-d888-4df6-ae4b-78c3dfed3423",
     "ccafb5c2-86dd-4bb2-883a-c13e3171227c"
    ],
    "package_ndc": [
     "63323-578-03",
     "63323-578-01",
     "63323-578-04",
     "63323-578-02",
     "63323-578-07",
     "63323-578-05",
     "63323-578-18",
     "63323-578-20",
     "63323-578-41",
     "63323-578-11",
     "63323-578-42",
     "63323-578-12"
    ],
    "unii": [
     "V92SO9WP2I"
    ]
   },
   "update_date": "07/30/2026",
   "therapeutic_category": [
    "Anesthesia"
   ],
   "dosage_form": "Injection",
   "presentation": "Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/30/2026",
   "update_type": "New",
   "initial_posting_date": "07/30/2026",
   "package_ndc": "65219-801-01",
   "generic_name": "Glycopyrrolate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA209328"
    ],
    "brand_name": [
     "GLYCOPYRROLATE"
    ],
    "generic_name": [
     "GLYCOPYRROLATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-801"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GLYCOPYRROLATE"
    ],
    "rxcui": [
     "1731582"
    ],
    "spl_id": [
     "516b2ac1-7eab-4d63-a0d0-97245858a1d0"
    ],
    "spl_set_id": [
     "250eeef7-b1a9-45e7-a927-7807232e10be"
    ],
    "package_ndc": [
     "65219-801-00",
     "65219-801-01"
    ],
    "unii": [
     "V92SO9WP2I"
    ]
   },
   "update_date": "07/30/2026",
   "therapeutic_category": [
    "Anesthesia"
   ],
   "dosage_form": "Injection",
   "presentation": "Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/30/2026",
   "update_type": "New",
   "initial_posting_date": "07/30/2026",
   "package_ndc": "63323-578-02",
   "generic_name": "Glycopyrrolate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA209328"
    ],
    "brand_name": [
     "GLYCOPYRROLATE"
    ],
    "generic_name": [
     "GLYCOPYRROLATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-578"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GLYCOPYRROLATE"
    ],
    "rxcui": [
     "238212",
     "1731582",
     "1731590"
    ],
    "spl_id": [
     "779dc924-ecc3-41cc-8cf9-a7354db4f763",
     "d528572e-598b-4c0e-b280-b083c73c017f"
    ],
    "spl_set_id": [
     "54458620-d888-4df6-ae4b-78c3dfed3423",
     "ccafb5c2-86dd-4bb2-883a-c13e3171227c"
    ],
    "package_ndc": [
     "63323-578-03",
     "63323-578-01",
     "63323-578-04",
     "63323-578-02",
     "63323-578-07",
     "63323-578-05",
     "63323-578-18",
     "63323-578-20",
     "63323-578-41",
     "63323-578-11",
     "63323-578-42",
     "63323-578-12"
    ],
    "unii": [
     "V92SO9WP2I"
    ]
   },
   "update_date": "07/30/2026",
   "therapeutic_category": [
    "Anesthesia"
   ],
   "dosage_form": "Injection",
   "presentation": "Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}